Genomics

Dataset Information

0

Mucosal exposure to non-tuberculous mycobacteria elicits B-cell mediated protection against pulmonary tuberculosis


ABSTRACT: Bacille Calmette Guerin (BCG) is the only licensed vaccine against Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB) disease. However, BCG has limited efficacy, necessitating the development of better vaccines. Non-tuberculous mycobacteria (NTM), a distinct lineage from Mtb, are opportunistic pathogens present in the environment. TB endemic countries experience higher exposure to NTM, but previous studies have not elucidated the relationship between NTM exposure and BCG efficacy. Therefore, we developed a mouse model (BCG+NTM) that mimics human BCG vaccination at an early stage and continuous NTM exposure via the oral route, including during TB infection. Our results show that BCG+NTM mice had improved protection against pulmonary TB correlating with increased pulmonary influx of B-cells, higher titers of anti-Mtb IgA and IgG antibodies in serum and airways, compared to mice vaccinated with BCG alone. Notably, the lungs of BCG+NTM mice developed B-cell aggregates expressing markers of germinal center formation as determined by spatial transcriptomics. We conclude a direct correlation between NTM exposure and protection from TB, with B-cells playing a crucial role.

ORGANISM(S): Mus

PROVIDER: GSE203037 | GEO | 2022/10/23

REPOSITORIES: GEO

Similar Datasets

2016-07-03 | E-GEOD-62423 | biostudies-arrayexpress
2020-01-01 | GSE139598 | GEO
2019-05-15 | PXD006141 | Pride
2016-01-01 | GSE62423 | GEO
2021-12-06 | GSE156422 | GEO
2024-02-16 | GSE224469 | GEO
2024-02-16 | GSE224467 | GEO
2015-03-31 | E-GEOD-67427 | biostudies-arrayexpress
2017-09-27 | GSE104287 | GEO
2023-06-19 | GSE218270 | GEO